Publication: Biopsy rate and positive predictive value for breast cancer in BI-RADS category 4 breast lesions
Issued Date
2010-07-01
Resource Type
ISSN
01252208
01252208
01252208
Other identifier(s)
2-s2.0-77955084834
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of the Medical Association of Thailand. Vol.93, No.7 (2010), 830-837
Suggested Citation
Cholatip Wiratkapun, Weeraya Bunyapaiboonsri, Bussanee Wibulpolprasert, Panuwat Lertsithichai Biopsy rate and positive predictive value for breast cancer in BI-RADS category 4 breast lesions. Journal of the Medical Association of Thailand. Vol.93, No.7 (2010), 830-837. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/29606
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Biopsy rate and positive predictive value for breast cancer in BI-RADS category 4 breast lesions
Other Contributor(s)
Abstract
Objective: To examine the biopsy rate and positive predictive value (PPV) for breast cancer in lesions categorized as BI-RADS (Breast Imaging reporting and Data System) category 4. Material and Method: The medical records of patients with BIRADS 4 breast lesion diagnosed at the breast diagnostic center, Ramathibodi Hospital between December 1, 2004 and December 31, 2005 were retrospectively reviewed. PPV was calculated for patients who had biopsy performed or had clinical follow-up for at least two years. The radiographic and pathological findings were compared. Results: The biopsy rate of 536 lesions categorized as BI-RADS 4 was 75% (403 of 536). Malignancy was found in 95 of 460 patients; or a PPV of 21%, PPVs for subcategories 4A, 4B and 4C, were 9%, 21% and 57%, respectively. The most common malignancy was invasive ductal carcinoma (67%). Patients with advanced age, having a clinically palpable breast mass of large size, with mammographic findings of architectural distortion and asymmetrical density were significantly associated with a higher risk of breast cancer. Conclusion: PPV for malignancy in the present study was comparable to previous studies. In subcategories 4B and 4C, the malignancy rate was higher than that in subcategory 4A.